Results 201 to 210 of about 839,545 (360)

How far will they go?: assessing the travel distance of current and former drug users to access harm reduction services [PDF]

, 2015
Sean T. Allen, Monica S. Ruiz, Allison O’Rourke   +2 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network. [PDF]

Therap Adv Gastroenterol
Pellegrini G, Spini A, Bellitto C, L'Abbate L, Ingrasciotta Y, Soardo F, Leoni O, Mazzone A, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Tuccori M, Gini R, Allotta A, Addario Pollina S, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Bernardi FF, Trama U, Spila Alegiani S, Mayer F, Massari M, Savarino EV, Variola A, Trifirò G.   +39 more
europepmc   +1 more source

Challenges Faced and Coping Strategies Adopted by Injecting Drug Users during COVID-19 Lockdown-A Qualitative Study. [PDF]

Indian J Community Med, 2023
Vashisht S, Jha S, Kant S, Thakur N, Rai S.   +4 more
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Burden, Risk Factors, and Knowledge of Non-fatal Opioid Overdose Among Injectable Drug Users: A Cross-sectional Study. [PDF]

Indian J Psychol Med
Das S, Sen S, Mondal S, Mondal M, Khatun Y, Sarkhel S, Saha I, Mukherjee S, Bhowmik K, Sarkar S, Neogi R, Rao R, Paramanik M, Bhattacharjee M, Basu A, Bhargava S, Ganguly S, Bhattacharjee S, Saha A, Chakrabarti A.   +19 more
europepmc   +1 more source

Novel Circovirus in Blood from Intravenous Drug Users, Yunnan, China. [PDF]

Emerg Infect Dis, 2023
Li Y, Zhang P, Ye M, Tian RR, Li N, Cao L, Ma Y, Liu FL, Zheng YT, Zhang C.   +9 more
europepmc   +1 more source

Opening remarks, Human Rights Watch/Open Society Institute Panel Discussion on the Human Rights of Drug Users in an era of HIV/AIDS, 1 April 2004 [PDF]

, 2004
Hunt, PH
core  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

An observational study on high-risk behaviour and treatment adherence among injecting drug users attending an opioid substitution therapy centre in a teaching institution of Kolkata. [PDF]

J Family Med Prim Care
Pal M, Dobe M.
europepmc   +1 more source